ITAT: Allows Pfizer’s initial year marketing spend as economic adjustment; Excludes ‘pass through cost’ from cost-base
Jan 11, 2022
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals